83 related articles for article (PubMed ID: 6172826)
1. [Fetomaternal micro-passage of AFP and early amniocentesis].
Nguyen The H; Pescia G; De Grandi P
Rev Med Suisse Romande; 1981 Nov; 101(11):891-4. PubMed ID: 6172826
[No Abstract] [Full Text] [Related]
2. [Biochemical and coagulation-physiology examinations before and after amniocentesis in early pregnancy].
Dame WR; Ebert C; Beckmann M; Quakernack K
Z Geburtshilfe Perinatol; 1979 Jun; 183(3):229-33. PubMed ID: 90435
[TBL] [Abstract][Full Text] [Related]
3. Fetal-maternal bleeding associated with genetic amniocentesis.
Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
[TBL] [Abstract][Full Text] [Related]
4. Fetomaternal hemorrhage after midtrimester genetic amniocentesis at King Chulalongkorn Memorial Hospital.
Tannirandorn Y; Romayanan O
J Med Assoc Thai; 1999 Nov; 82(11):1089-93. PubMed ID: 10659542
[TBL] [Abstract][Full Text] [Related]
5. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
6. [Prenatal diagnosis of genetic diseases during the second trimester of pregnancy, II: results].
Dallaire L; Melançon SB; Potier M; Gagnon M; Boisvert J; Lortie G
Union Med Can; 1982 Apr; 111(4):299-310. PubMed ID: 6178197
[No Abstract] [Full Text] [Related]
7. Raised maternal serum-alpha-fetoprotein levels and spontaneous fetomaternal transfusion.
Los FJ; de Wolf BT; Huisjes HJ
Lancet; 1979 Dec; 2(8154):1210-2. PubMed ID: 92622
[TBL] [Abstract][Full Text] [Related]
8. Prenatal cytogenetic screening.
Simpson JL
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
[No Abstract] [Full Text] [Related]
9. [Alpha fetoprotein and HbF cells in the maternal blood and their modification through amniocentesis].
Maas DH; Hoppe B; Weitzel HK
Fortschr Med; 1979 Jun; 97(21):981-6. PubMed ID: 86491
[TBL] [Abstract][Full Text] [Related]
10. Midtrimester amniocentesis. Indications, technique, risks and potential for prenatal diagnosis.
Roberts NS; Dunn LK; Weiner S; Godmilow L; Miller R
J Reprod Med; 1983 Mar; 28(3):167-88. PubMed ID: 6189994
[No Abstract] [Full Text] [Related]
11. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
12. [AFP and HbF determination in maternal blood as a parameter of fetomaternal microtransfusion in interventions of the pregnant uterus].
Alsheimer B; Dericks-Tan JS; Taubert HD
Geburtshilfe Frauenheilkd; 1985 Oct; 45(10):727-30. PubMed ID: 2415423
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
14. [Early amniocenthesis for the diagnosis of fetal abnormalities (author's transl)].
Drazancić A; Zergollern L; Suchanek E
Lijec Vjesn; 1980; 102(7-8):361-6. PubMed ID: 6169967
[No Abstract] [Full Text] [Related]
15. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
17. [Reducing the number of amniocenteses in women older than 35 years using serum markers levels?].
Aymé S
Rev Epidemiol Sante Publique; 1994; 42(5):468-9. PubMed ID: 7526423
[No Abstract] [Full Text] [Related]
18. The relation between maternal serum alpha-fetoprotein levels and fetomaternal haemorrhage.
Hay DL; Barrie JU; Davison GB; Buttery BW; Horacek I; Pepperell RJ; Fliegner JR
Br J Obstet Gynaecol; 1979 Jul; 86(7):516-20. PubMed ID: 89863
[TBL] [Abstract][Full Text] [Related]
19. Fetomaternal transfusion after amniocentesis and cordocentesis.
Sikovanyecz J; Horváth E; Pásztor N; Keresztúri A; Szabó J; Pál A
Ir J Med Sci; 2011 Sep; 180(3):697-701. PubMed ID: 21190089
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
